Glomerular repair retardation via blocking of angiotensin ii type 1a receptor pathway in a mouse glomerulonephritis model

Nephron - Experimental Nephrology

Volumn 122, Issue 1-2, 2013, Pages 13-22

  Hayashi, Waka ^a   Obata, Yoko ^a,b   Nishino, Tomoya ^a   Abe, Shinichi ^a   Io, Kumiko ^a   Furusu, Akira ^a   Abe, Katsushige ^e   Miyazaki, Masanobu ^c   Sugaya, Takeshi ^f   Koji, Takehiko ^d   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c Miyazaki Clinic   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e Jinikai Hospital   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Glomerulonephritis; Habu snake venom; Renin angiotensin aldosterone system; Vascular endothelial growth factor

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II TYPE 1A RECEPTOR ANTAGONIST; CD31 ANTIGEN; COLLAGEN TYPE 4; HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GLOMERULAR REPAIR; GLOMERULONEPHRITIS; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TISSUE REPAIR;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; COLLAGEN TYPE IV; CROTALID VENOMS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TETRAZOLES; TRIMERESURUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874256282     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000346954     Document Type: Article

References (31)

1. Aros C, Remuzzi G: The renin-angiotensin system in progression, remission and regression of chronic nephropathies. J Hypertens 2002; 20:S45-S53.
2. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1998; 45: 205-251.
3. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, Murakami K: Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 1995; 270: 18719-18722.
4. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995; 92: 3521-3525.
5. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, Nabi AH, Nishiyama A, Sugaya T, Hayashi M, Inagami T: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006; 17: 1950-1961.
6. Kato H, Ishida J, Nagano K, Honjo K, Sugaya T, Takeda N, Sugiyama F, Yagami K, Fujita T, Nangaku M, Fukamizu A: Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Lab Invest 2008; 88: 731-739.
7. Matsuura T, Kumagai H, Onimaru H, Kawai A, Iigaya K, Onami T, Sakata K, Oshima N, Sugaya T, Saruta T: Electrophysiological properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice. Hypertension 2005; 46: 349-354.
8. Ohwada K, Watanabe K, Okuyama K, Ohkawara Y, Sugaya T, Takayanagi M, Ohno I: The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma. Clin Exp Allergy 2007; 37: 1720-1727.
9. Wenzel UO, Thaiss F, Helmchen U, Stahl RA, Wolf G: Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Kidney Int 2002; 61: 1020-1029.
10. Takazawa Y, Maeshima Y, Kitayama H, Yamamoto Y, Kawachi H, Shimizu F, Matsui H, Sugiyama H, Yamasaki Y, Makino H: Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors. Kidney Int 2005; 68: 704-722.
11. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi T: Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002; 109: 603-611.
12. Kurosaka M, Suzuki T, Hosono K, Kamata Y, Fukamizu A, Kitasato H, Fujita Y, Majima M: Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. Biomed Pharmacother 2009; 63: 627-634.
13. Morita T, Yamamoto T, Churg J: Mesangiolysis: an update. Am J Kidney Dis 1998; 31: 559-573.
14. Kitamura H, Sugisaki Y, Yamanaka N: Endothelial regeneration during the repair process following habu-snake venom induced glomerular injury. Virchows Arch 1995; 427: 195-204.
15. Abe-Yoshio Y, Abe K, Miyazaki M, Furusu A, Nishino T, Harada T, Koji T, Kohno S: Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in habu snake venom-induced glomerulonephritis. Virchows Arch 2008; 453: 97-106.
16. Xia Z, Abe K, Furusu A, Miyazaki M, Obata Y, Tabata Y, Koji T, Kohno S: Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. Am J Nephrol 2008; 28: 34-46.
17. Davis KM, Nakamura S, Weiser JN: Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 2011; 121: 3666-3676.
18. Oyamada N, Sone M, Miyashita K, Park K, Taura D, Inuzuka M, Sonoyama T, Tsujimoto H, Fukunaga Y, Tamura N, Itoh H, Nakao K: The role of mineralcorticoid receptor expression in brain remodeling after cerebral ischemia. Endocrinology 2008; 149: 3764-3777.
19. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 1995; 147: 1715-1727.
20. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
21. Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis. Nephron 1998; 79: 206-214.
22. Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) 1999; 77: 527-543.
23. Ferrara N: Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794-814.
24. Kelly DJ, Hepper C, Wu LL, Cox RA, Gilbert RE: Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model. Nephrol Dial Transplant 2003; 18: 1286-1292.
25. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001; 159: 599-608.
26. Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ: Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg 2007; 204: 996-1005.
27. Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J: Renoprotective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia 2012; 55: 566-578.
28. Feliers D, Lee MJ, Ghosh-Choudhury G, Bomsztyk K, Kasinath BS: Heterogeneous nuclear ribonucleoprotein K contributes to angiotensin II stimulation of vascular endothelial growth factor mRNA translation. Am J Physiol Renal Physiol 2007; 293:F607-F615.
29. Shi RZ, Wang JC, Huang SH, Wang XJ, Li QP: Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells. Exp Cell Res 2009; 315: 10-15.
30. Amaya K, Ohta T, Kitagawa H, Kayahara M, Takamura H, Fujimura T, Nishimura G, Shimizu K, Miwa K: Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol 2004; 25: 849-856.
31. Schmidt D, Textor B, Pein OT, Licht AH, Andrecht S, Sator-Schmitt M, Fusenig NE, Angel P, Schorpp-Kistner M: Critical role for NFkappaB-induced JunB in VEGF regulation and tumor angiogenesis. EMBO J 2007; 26: 710-719.